Streetbeat News

Analyst Ratings

BDTX

Piper Sandler analyst Joseph Catanzaro has maintained an Overweight rating on Black Diamond Therapeutic (NASDAQ:BDTX) and raised the price target from $12 to $15.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:01 pm

BBY

In the last three months, 16 analysts have provided ratings for Best Buy Co (NYSE:BBY), ranging from bullish to bearish. The average 12-month price target is $103.19, reflecting a 12.99% increase from the previous target. Analysts have recently raised their price targets, indicating positive sentiment. Best Buy's financial performance shows strong market presence, efficient cost management, and conservative debt management.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:01 pm

AZO

Unusual options activity has been detected for AutoZone (NYSE:AZO), with a significant amount of bearish sentiment among large investors. The options trades include 10 puts and 5 calls, with a total bearish sentiment of 53%. The stock is currently trading at $3042.63, with an anticipated earnings release in one day. Analysts have mixed ratings, with price targets ranging from $3200 to $3350.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:00 pm

COST

Costco Wholesale (NASDAQ:COST) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 3.75% to $920.14. Analysts have frequently updated their recommendations, reflecting evolving market conditions and company performance. Costco's financial performance is strong, with impressive revenue growth, net margin, ROE, and ROA, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:00 pm

EVGO

In the past three months, 11 analysts have rated EVgo (NASDAQ:EVGO), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $4.73. EVgo has shown strong revenue growth but faces challenges with profitability and asset efficiency.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:00 pm

HD

Analysts have mixed views on Home Depot (NYSE:HD) with recent evaluations showing a slight increase in the average 12-month price target. The company's financial performance is strong, but it faces challenges with high debt levels.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:00 pm

TEAM

Atlassian (NASDAQ:TEAM) received mixed analyst ratings over the past three months, with a recent downward trend in price targets. The average 12-month price target is now $209, down from $225.91. Despite a 20.5% revenue growth, Atlassian faces challenges with profitability, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:00 pm

TNDM

Analysts have varied ratings for Tandem Diabetes Care (NASDAQ:TNDM), with a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $50.57. Tandem Diabetes Care has shown revenue growth but faces challenges with negative net margins and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:00 pm

BHVN

Piper Sandler analyst Christopher Raymond has maintained an Overweight rating on Biohaven (NYSE:BHVN) and raised the price target from $66 to $76.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:00 pm

COST

Melius Research has initiated coverage on Costco Wholesale with a Hold rating and set a price target of $950.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:56 pm